Mycophenolate Sodium
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Gastrointestinal Symptoms
Conditions
Gastrointestinal Symptoms, Heart Transplantation
Trial Timeline
Jun 1, 2006 → Dec 1, 2009
NCT ID
NCT00574197About Mycophenolate Sodium
Mycophenolate Sodium is a approved stage product being developed by Novartis for Gastrointestinal Symptoms. The current trial status is completed. This product is registered under clinical trial identifier NCT00574197. Target conditions include Gastrointestinal Symptoms, Heart Transplantation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00646737 | Approved | Completed |
| NCT00574197 | Approved | Completed |
| NCT00542763 | Phase 1 | Completed |
Competing Products
20 competing products in Gastrointestinal Symptoms